Dr. Blake Dewayne Babcock, MD

Dr. Babcock practices at AdventHealth Porter in Denver, Colorado, part of AdventHealth.

Dr. Babcock's NPI, 1578873758, was assigned on October 20, 2010. Dr. Babcock holds Colorado license DR.67355.

Dr. Babcock's primary practice is AdventHealth Porter, at 2525 S Downing St, Denver, CO 80210 in Denver County. The practice phone is (303) 778-1955.

Dr. Babcock's primary practice is AdventHealth Porter in Denver, Colorado, part of AdventHealth. Dr. Babcock is also affiliated with AdventHealth Parker. The medical group on file is AdventHealth Transplant Institute North Billings. Dmand AI also links Dr. Babcock to 1 more group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Babcock practices, 4 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Babcock's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Babcock's licenses on file in 3 states: Colorado, California and Florida.

CMS data shows 24 Medicare services from Dr. Babcock across 2 procedure codes in 2024, all of them office visits, for 44 Medicare patients. Medicare paid $3,241 for them. Every service was in an office.

CMS counts 44 Medicare patients who saw Dr. Babcock in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Babcock's median patient age at 66, with 51% women.

In 2024, Dr. Babcock wrote 32 Medicare Part D claims for 24 patients. 91% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $74 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Babcock for performance year 2024, reported as part of a group. Dr. Babcock accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Babcock as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Babcock, published from 2013 to 2020. 2015 was the busiest year, with 2. The most frequent topics are Proto-Oncogene Proteins c-mdm2, Tumor Suppressor Protein p53 and Adenocarcinoma. Dr. Babcock has published most often in Ann Clin Lab Sci. Dr. Babcock's most frequent co-authors are Wilbur B. Bowne, MD, Elizabeth Moran Gleeson, MD and Maheswari Senthil, MD.

CMS Open Payments shows 41 general payments to Dr. Babcock from 11 drug and device companies from 2016 to 2024. Education make up the largest share, 84% of the total. Intuitive Surgical, Inc. paid the most, $14,599.